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SUMMARY
Elastase, but not PR3, induces proteinuria associated with loss of glomerular basement membrane
(GBM) heparan sulphate after in vivo renal perfusion in rats. PR3 and elastase are cationic neutral serine
proteinases present in the azurophilic granules of polymorphonuclear leucocytes. Release of these
proteolytic enzymes along the glomerular capillary wall may induce glomerular injury. Here, we
investigated the effects of PR3 and elastase on the induction of proteinuria and glomerular injury after
renal perfusion of these enzymes in Brown–Norway rats. Perfusion of active elastase induced a dose-
dependent proteinuria 24 h after perfusion, while inactivated elastase did not. Perfusion of comparable
amounts of active PR3 did not induce proteinuria. Light and electron microscopy showed no
morphological abnormalities in any experimental group. However, immunohistology revealed that
proteinuria occurring after perfusion of active elastase was associated with a strong reduction in
intraglomerular expression of the heparan sulphate side chain and, to a lesser extent, of the protein core
of heparan sulphate proteoglycans (HSPG). In vitro, both elastase and PR3 digested HSPG. However,
PR3 bound to a lesser extent to HSPG than elastase. We conclude that elastase, but not PR3, induces
proteinuria after in vivo renal perfusion. This differential effect probably relates to different binding to
the GBM of those enzymes due to differences in their isoelectric points. Degradation of heparan sulfate
proteoglycans, leading to the disappearance of their side chains that contribute to the polyanionic
structure of the GBM, appears to be involved in the induction of proteinuria after perfusion of elastase.
Keywords serine proteases neutrophils glomerulonephritis extracellular matrix isoelectric
point
INTRODUCTION
Polymorphonuclear leucocytes (PMN) contain various proteases in
their granules which are released into the extracellular space upon
activation. It has long been recognized that release of these
proteases by PMN adherent to the glomerular capillary wall may
play an important role in the induction of glomerular injury, as
observed in PMN-dependent glomerulonephritis [1]. In this
respect, most attention has been focused on the cationic neutral
serine proteases elastase and cathepsin G, which are present in the
azurophilic granules of PMN [2]. Evidence for the involvement of
these neutral serine proteases in glomerular injury has been
provided by a number of studies. In vitro, it has been shown that
elastase and cathepsin G degrade several constituents of the
glomerular basement membrane (GBM), including fibronectin,
laminin, and collagen type IV [3–5]. In addition, Johnson et al.
showed that in vivo renal perfusion of g quantities of active
elastase and cathepsin G results in severe proteinuria, while the
equally cationic but inactivated enzymes do not [6]. Moreover,
Schrijver et al. found that Beige mice, whose PMN are deficient in
elastase and cathepsin G, do not develop proteinuria after induction
of anti-GBM antibody disease [7].
Recently, a novel proteolytic enzyme isolated from human
PMN was described as PR3. PR3 has been characterized as a
neutral serine protease with a mol. wt of 29 kD and an isoelectric
point of 9.1 [8]. Like cathepsin G and elastase, it is present in the
azurophilic granules of PMN and released after stimulation [9].
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Since the discovery that the majority of anti-neutrophil cytoplas-
mic antibodies (ANCA) in Wegener’s granulomatosis (WG) are
directed against PR3, the enzyme has attracted considerable inter-
est and has been the focus of several studies [10,11]. Intratracheal
insufflation of PR3 in hamsters has been shown to cause emphy-
sema, and, in vitro, PR3 is capable of degrading several constitu-
ents of the GBM [8,12]. Furthermore, we recently showed that in
renal biopsies from patients with WG, PR3 and elastase are
localized extracellularly in renal tissue, suggesting that release of
these proteolytic enzymes may contribute to glomerular damage as
seen in WG [13]. However, in vivo evidence concerning the role of
PR3 in glomerular injury is lacking. We therefore studied the
effects of PR3 on the induction of proteinuria after renal perfusion
of g quantities of the active enzyme in Brown–Norway rats and
compared the effects with those obtained after renal perfusion of
elastase.
Recently, Klebanoff et al. showed that elastase is capable of
degrading heparan sulphate proteoglycans (HSPG) of subendothe-
lial matrix in vitro, suggesting that proteolytic cleavage of HSPG
may be involved in neutrophil-associated proteinuria [14]. HSPG
consist of a core protein bearing negatively charged heparan
sulphate glycosaminoglycan chains and are considered to be
main determinants for the charge-dependent permeability of the
glomerular capillary wall [15]. In rats, the nephrotic syndrome is
associated with a loss of GBM HSPG, and antibodies to basement
membrane HSPG core protein and heparan sulphate are nephrito-
genic [16–18]. Therefore, we studied glomerular HSPG core
protein and side chain expression after in vivo renal perfusion of
elastase and PR3 in relation to the occurrence of proteinuria. We
compared the results with the in vitro binding and degradation of
HSPG by both enzymes.
MATERIALS AND METHODS
Animals
All experiments were performed in conventionally housed, 3-month-
old Brown–Norway rats. Animals were fed ad libitum with standard
chow (Hope Farms, Woerden, The Netherlands).
Enzyme activity assay
Enzymatic activity of PR3 and elastase was quantified by the
cleavage of the synthetic ester, Boc-alanine-p-nitrophenyl ester
(Sigma Chemical Co., St Louis, MO), according to the method of
Rao et al. [12]. Assays were carried out in a 200-l final volume of
0.05 M phosphate buffer pH 7.5 containing 0.5 mM substrate and
were run and quantified in a 96-well microtitre plate (Greiner Inc.,
Alphen a/d Rijn, The Netherlands) using a Titertek multiscan
(Titertek Flow Labs, Zwanenburg, The Netherlands) for analysis
read at 405 nm. One unit of enzymatic activity was defined as the
amount which cleaved 1 mol of substrate in 1 min at 228C.
Proteolytic assay
Cleavage of casein was assayed according to the methods of
Twining [19]. For each sample, 0.04% (w/v) resorufin-labelled
casein (Boerhinger Mannheim Biochemica, Mannheim, Germany),
0.2 M Tris–HCl pH 7.8, 0.02 M CaCl2, and 1 g PR3 or elastase
were incubated in a total volume of 200 l at 378C for 16 h. The
reaction was stopped by adding 480 l 5% (w/v) trichloro acetic
acid (TCA). A precipitate was allowed to form at 378C for 10 min,
after which the samples were centrifuged at 13 000 g for 5 min.
Next, 400 l of TCA-soluble supernatant were neutralized with
600 l of 0.5 M Tris–HCl pH 8.8. Absorbance was read at 574 nm
against sample blank. Total hydrolysis was determined by incuba-
tion with 1 mg pronase (Boehringer Mannheim Biochemica) for
16 h at 378C.
ELISA for leucocyte enzymes
An antigen capture ELISA was used to detect PR3, myeloperox-
idase (MPO) or elastase, as described [20]. Briefly, microtitre
plates (Inotech, Breda, The Netherlands) were incubated with goat
anti-mouse IgG (Jackson, West Grove, PA). After being washed,
plates were incubated with mouse MoAbs against PR3, MPO
(MoAb 12.8 and MoAb 4.15, respectively; Central Laboratory of
the Blood Transfusion Service, Amsterdam, The Netherlands) or
elastase (Dakopatts, Glostrup, Denmark). After another wash,
100 l of different dilutions of the test samples in the incubation
buffer were added for 1 h at 378C. Bound leucocyte enzymes were
then detected with rabbit anti-PR3, rabbit anti-MPO and rabbit
anti-elastase (both from Dakopatts). Bound antibody was detected
with alkaline phophatase-labelled goat anti-rabbit IgG and p-
nitrophenyl phosphate disodium (both from Sigma Chemical
Co.) as a substrate. Plates were read at 405 nm.
Proteinase 3
PR3 was purified using the methods of Ballieux et al. with minor
modifications, as described previously [21]. Briefly, -granules
were isolated from normal human leucocytes by sequential nitro-
gen cavitation and centrifugation on 84% Percoll. Pooled -
granules were subjected to two rounds of 1% Triton X-100
(Kock Light Labs, Ltd, Colnbrook, UK) extraction. This -granule
extract was used as the starting material for a two-step chromato-
graphic isolation procedure for the isolation of PR3. Initially, the
-granule extract was applied to a 28  1.5 Biorex 70 (BioRad
Labs, Richmond, CA) column followed by fast performance liquid
chromatography (FPLC) gel filtration over a 2.6  60 cm Super-
dex 75 column (Pharmacia LKB). Fractions were tested for
esterolytic activity on Boc-alanine-p-nitrophenyl ester and for
detection of PR3 antigen by ELISA. Purity was checked by
SDS–PAGE, and contamination with elastase, cathepsin G or
MPO was excluded by ELISA. The PR3-positive fractions were
pooled, dialysed against distilled water, lyophilized and resus-
pended in PBS pH 7.4. Protein concentration was measured
according to Bradford using bovine serum albumin (BSA) as
standard. Aliquots of 500l containing 500g enzyme were
stored at ÿ808C until use.
Elastase
Lyophilized purified human neutrophil elastase was purchased
from Calbiochem-Behring Co. (La Jolla, CA). This elastase was
dissolved in PBS pH 7.4 just before use. In some experiments,
elastase was irreversibly inactivated by the specific elastase inhi-
bitor MSAAPV-chloromethyl ketone (Sigma Chemical Co.).
Stimulation of normal human PMN
For comparative purposes, the amounts of elastase and PR3
released by activated human PMN were measured. Briefly,
EDTA blood was drawn from six healthy donors and PMN were
isolated by centrifugation on a lymphoprep density gradient
(Nycomed Pharma AS, Oslo, Norway). Contaminating erythro-
cytes were lysed with ammonium chloride and cell concentrations
were adjusted to 107/ml in Hanks’ balanced salt solution (HBSS;
GIBCO, Breda, The Netherlands). PMN were activated by preincu-
bation with cytochalasin B 5 g/ml (18015; Serva, Heidelberg,
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Germany) for 5 min at 378C followed by a 30-min incubation with
10–7 M formyl-methionyl-leucyl-phenylalanine (fMLP) (Sigma
Chemical Co.) or HBSS to estimate spontaneous release. Subse-
quently, cells were centrifuged at 1000 g for 5 min and super-
natants were assayed for PR3 and elastase content by antigen
capture ELISA, as described above, using the enzyme preparation
used in the perfusion studies as standard. Values were corrected for
spontaneous release.
Renal perfusion
Perfusion of the left kidney was performed according to the
methods of Hoyer et al. with minor modifications, as described
[22] Briefly, rats were anaesthetized with halothane, O2, and NO2.
The aorta and vena cava were then exposed and the tributaries
ligated. A temporary clamp was placed on the aorta above the left
renal artery and on the renal vein. A needle was inserted in the
aorta through a puncture hole and advanced up to the level of the
left renal artery. A puncture in the left renal vein allowed blood and
perfusion fluids to escape which were collected in cotton wool.
Initially, PBS (378C, pH 7.4) was perfused until no visible blood
escaped from the punctured renal vein. Then, rats were perfused
with different doses of active elastase (15g, n  3; 25g, n  6;
and 50g, n  6) or PR3 (50g, n  4; 100g, n  3; and
300 g, n  3) in 0.5 ml PBS to establish a dose–response
relationship for both enzymes. In addition, four rats were perfused
with 50g/0.5 ml of MSAAPV chloromethyl ketone-inactivated
elastase. Control rats were perfused with PBS alone. After 3 min,
kidneys were cleared with PBS and blood flow was restored. Total
ischaemia time was always <11 min. After surgery, rats were
allowed to recover from anaesthesia for 2 h under a heat lamp.
Rats were then placed in metabolic cages for 24 h with free access
to water, and urine was collected.
Urine analysis
Total protein content of the urine samples was measured with the
quantitative biuret method. Proteinuria was further characterized
by 12% SDS–PAGE under non-reducing conditions.
Light microscopy
Twenty-four hours after perfusion rats were killed. Blood was
displaced from both kidneys by perfusion of PBS at 48C. Tissue
from both kidneys was processed for light microscopy and immu-
nofluorescence. For light microscopy, tissue was fixed in 2%
paraformaldehyde in PBS and embedded in Technovit 8100
glycolmethacrylate (Kulzer GmbH, Wehrheim, Germany) for
morphological detail, as described [23]. Sections (2 m) were
cut on a Reichert Jung Supercut plastic microtome and stained
with periodic acid-Schiff (PAS) or periodic acid silver methamine
(MZ).
Electron microscopy
Renal tissue was fixed overnight in 2% glutaraldehyde in 0.1 M
phosphate buffer pH 7.4 at 48C. Tissue was post-fixed in 1% OsO4
for 2 h at 48C and serially dehydrated in ethanol, then embedded in
Epon and thin sections (60 nm) were cut. Sections were stained
with uranyl acetate and lead citrate and examined with a Philips
EM 201 electron microscope.
Localization of PR3 and elastase
Separate experiments were performed to study the localization of
elastase and PR3 after perfusion by indirect immunofluorescence.
In these experiments, 50g of active elastase (n  2) or PR3
(n  2) were perfused as described above. Ten minutes after
reperfusion, rats were killed. For localization of PR3 and elastase,
renal tissue was snap-frozen in isopenthane and 2-m crysostat
sections were cut. Sections were fixed in acetone-buffered formalin
9% according to Pryzwansky et al. [24] followed by incubation
with 10% normal goat serum. PR3 and elastase were detected by
incubating sections with rabbit anti-PR3 and rabbit anti-elastase
(Dakopatts). Binding was visualized with FITC-labelled goat
F(ab)2 anti-rabbit IgG (Southern Biotechnology Associates, Bir-
mingham, AL).
Immunofluorescence
For indirect immunofluorescence (IIF) renal tissue was snap-frozen
in isopenthane and 2-m sections were cut. Sections were fixed in
acetone and subsequently incubated with 10% normal rabbit or
goat serum, depending on the conjugate used. Detection of heparan
sulphate (HS) side chain was done using hybridoma supernatant of
mouse anti-rat HS side chain (MoAb JM-403) [21]. Binding was
visualized by FITC-labelled goat anti-mouse IgM (Nordic, Til-
burg, The Netherlands). To detect rat HSPG, we used goat
antiserum against human HS core protein, which has been shown
to cross-react with rat HSPG [21]. FITC-labelled rabbit anti-goat
IgG was used as conjugate (Dakopatts). The intraglomerular
expression of S-laminin, fibronectin, and collagen type IV was
investigated using mouse anti-rat S-laminin, rabbit anti-human
fibronectin (Sigma Chemical Co.), and goat anti-human collagen
type IV (Southern Biotechnology), which have been shown to
cross-react with rat fibronectin and collagen type IV. The follow-
ing conjugates were used: goat anti-mouse IgG FITC (Southern
Biotechnology), goat F(ab)2 anti-rabbit, and rabbit F(ab)2 anti-goat
FITC (both from Dakopatts). For all stainings, staining intensity
was scored on a semiquantitative scale (3 +): –, absent; ,
weak; , mild; , intermediate; , strong, using the right
non-perfused kidney as reference. In addition, kidney sections
were double-stained with anti-HS MoAb JM-403 and goat anti-
HSPG core protein. For this purpose, sections were sequentially
incubated with: (i) MoAb JM-403; (ii) TRITC-labelled goat anti-
mouse IgM (Southern Biotechnology); (iii) goat anti-HSPG core
protein; (iv) FITC-labelled rabbit F(ab)2 anti-goat (Dakopatts). The
double-staining experiments included the following controls: (i)
omitting MoAb JM-403 or goat anti-HSPG core or both; (ii)
incubation of MoAb JM-403 or goat anti-HSPG core with the
conjugate used for the detection of the other antibody in the double
staining.
In vitro studies
First, the effects of PR3 and elastase on HSPG degradation were
studied in vitro. For this purpose, microtitre plates (Greiner) were
coated with HSPG from the mouse EHS tumour (Sigma; 125 ng/
well) overnight at room temperature. Plates were washed with PBS
and incubated with elastase, MSAAVP chloromethyl ketone-inac-
tivated elastase, PR3 or PMSF-inactivated PR3 in concentrations
ranging from 40g/ml to 2.4 ng/ml for 1 h at 378C. After washing
with PBS–Tween (0.05%), plates were incubated with the MoAb
directed against HS (MoAb JM-403) for 1 h at 378C, followed by
peroxidase-labelled rabbit anti-mouse (1 h, 378C). Binding was
detected using tetramethyl benzidine (TMB; Sigma) as substrate.
Plates were read at 450 nm. To assess the binding of PR3 and
elastase to EHS–HSPG, microtitre plates were coated with EHS–
HSPG and incubated with inactivated elastase and PR3 as
described above. Then bound elastase and PR3 were detected by
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incubation with rabbit anti-elastase or rabbit anti-PR3 for 1 h at
378C. Bound antibody was detected by incubation with perox-
idase-labelled goat anti-rabbit (Sigma Chemical Co.) for 1 h at
378C. Plates were developed and read at 450 nm as described
above.
Statistical analysis
Results were analysed for statistical significance by Student’s t-
test. All results are reported as mean  s.e.m. P <0.05 was
regarded as significant.
RESULTS
Characterization of PR3 and elastase
On SDS–PAGE the purified PR3 preparation migrated as a triplet
around 30 kD (Fig. 1). Furthermore, by ELISA, no contamination
with MPO, cathepsin G or elastase was detected. As shown in
Table 1, enzymatic activity of purified PR3 was 2.5 or 5 times less
than that of elastase as tested on resorufin-labelled casein and the
synthetic substrate Boc-alanine-p-nitrophenyl ester, respectively.
To estimate the amounts of PR3 and elastase which could be
released by activated PMN, 107 isolated PMN from six normal
donors were pretreated with cytochalasin B and stimulated with
10–7 M fMLP. From Table 2 it can be seen that under these
conditions  3 times more PR3 than elastase was released extra-
cellularly, as quantified by ELISA.
Localization of PR3 and elastase
Infused PR3 and elastase were localized for only a short period in
the glomeruli. Ten minutes after perfusion no glomeruli stained
positive for elastase and PR3, as detected by IIF. However, strong
staining was observed in tubular epithelial cells (Fig. 2). Twenty-
four hours after perfusion elastase or PR3 were detected no more in
glomeruli or in tubuli.
Proteinuria after renal perfusion of elastase and PR3
Renal perfusion of 50 g active elastase induced severe proteinuria
24 h after perfusion (Table 3). The degree of elastase-induced
proteinuria was dose-dependent. Proteinuria was not observed in
rats perfused with 50 g of inactivated elastase or PBS. Further-
more, perfusion of active PR3 did not result in proteinuria at all
doses studied. Further characterization of elastase-induced protei-
nuria by SDS–PAGE revealed that most urinary proteins were low
molecular weight proteins (Fig. 3).
Morphology
Twenty-four hours after perfusion, samples from left and right
kidneys were taken and studied morphologically by light and
electron microscopy. By light microscopy, no morphological
abnormalities such as disruption of the GBM or infiltration of
PMN and monocytes were seen in any group. In some elastase-
perfused rats protein absorption droplets were observed in tubular
epithelial cells. In addition, electron microscopy did not reveal
glomerular damage in any group. No detachment or lysis of
glomerular endothelial cells or fusion of epithelial foot processes
were noted.
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Fig. 1. Migration of PR3 on a 12% SDS–PAGE gel. For comparison,
migration of elastase is also shown (Ela).
Table 1. Cleavage of Boc-alanine-p-nitrophenyl ester and casein by PR3
and elastate
Boc-alanine-p-nitrophenyl Casein resorufin-labelled
Enzyme (mU/mg protein)* (%)†
PR3 1086 21 3
Elastase 5140 52 6
* Cleavage of Boc-alanine-p-nitrophenyl ester is expressed in milli-
units, where 1 unit is defined as the amount of protein which cleaves 1mol
of substrate in 1 min at 228C.
† Proteolytic activity on resorufin-labelled casein is expressed as a mean
percentage of total hydrolysis by pronase. Values represent means s.e.m.
of three separate experiments done in triplicate
Table 2. Release of PR3 and elasstase from
normal donor granulocytes afer stimulation with
10ÿ7 M fMLP as measured by antigen capture
ELISA
Donor PR3 Elastase
1 12 4.5
2 10 4.7
3 7.7 3.2
4 14.5 3.3
5 10.3 3.1
6 8.8 2.4
Mean 10:6 2:2 3:5 0:8
Values represent g s.e.m. per 107 PMN.
Glomerular staining of GBM components
GBM staining of HSPG and HS was studied in kidney sections
from all groups by IIF using a MoAb directed against HS (MoAb
JM-403) and goat antiserum directed against the core protein of
HSPG (Table 3). In kidney sections of PBS-perfused rats strong
staining of the GBM and Bowman’s capsule in a fine granular to
linear pattern was observed with MoAb JM-403 (Fig. 4A).
Essentially the same staining pattern was obtained with poly-
clonal antiserum against the HSPG core protein (Fig. 4B).
Furthermore, the pattern and intensity of staining was not
different from that in right, non-perfused, kidney sections for
both antibodies. However, after perfusion of 50 g active elas-
tase, staining for HS with MoAb JM-403 was almost completely
absent in the glomeruli (Fig. 4E). In some cases staining of
Bowman’s capsule was still positive. In these sections expres-
sion of HSPG core protein was also reduced compared with
sections from the right non-perfused kidney and PBS-infused
rats, although to a lesser extent than for HS (Fig. 4F). Infusion of
lower doses of active elastase also resulted in a reduction in
staining for HS along the GBM, but no apparent decrease in
expression of HSPG core protein was noted (not shown). In
contrast to the elastase-perfused kidneys, no decrease in glomer-
ular HS or HSPG core protein expression was observed after
infusion of 50 g inactivated elastase nor of active PR3 at any
dose studied (Fig. 4C,D).
In addition to HS and HSPG core protein, glomerular expres-
sion of S-laminin, fibronectin, and collagen type IV was studied by
IIF. In kidney sections of PBS-perfused rats a linear staining along
the GBM together with a prominent mesangial staining was
obtained with the mouse antibody against S-laminin. No differ-
ences in staining intensity were observed in kidney sections from
rats perfused with active elastase and all other groups. Further-
more, for fibronectin and collagen type IV also no changes in
expression were observed in all groups (not shown).
Effects of PR3 and elastase on HSPG in vitro
The in vivo results led us to investigate HSPG degradation by
elastase and PR3 in vitro. As shown in Fig. 5a, incubation of EHS–
HSPG coated to microtitre plates with active PR3 or elastase
resulted in a dose-dependent loss of HS as detected with MoAb
JM-403 for both enzymes. The loss of anti-HS reactivity could be
prevented when the enzymes were inactivated. However, at lower
concentrations elastase seemed to be more active than PR3 in
degrading HSPG. In order to assess whether this difference was
due to a lower degree of binding of PR3 to HSPG, we incubated
microtitre plates coated with EHS–HSPG with inactivated PR3
and elastase and detected the amount of enzyme binding to HSPG.
As shown in Fig. 5b, PR3 seems to bind less strongly to HSPG than
elastase.
DISCUSSION
Activation of PMN adherent to the glomerular capillary wall leads
to the production of reactive oxygen species and the release of their
granule constituents, including cationic neutral serine proteinases.
At the site of degranulation high concentrations of these proteolytic
enzymes may be reached which may cause glomerular injury by
proteolytic cleavage of GBM constituents and lysis or detachment
of glomerular endothelial cells. In the present study we evaluated
the effects of the human PMN-derived neutral serine proteinases
elastase and PR3 on the induction of proteinuria and the degrada-
tion of GBM components after in vivo renal perfusion. We showed
that infusion of g quantities of active elastase induced a dose-
dependent proteinuria 24 h after perfusion, while inactivated
equally cationic elastase did not increase the urinary excretion of
proteins, demonstrating that the proteolytic activity of elastase was
responsible for this effect. These results confirm the data of
Johnson et al., who were the first to show the ability of PMN-
derived neutral serine proteinases to induce proteinuria after renal
perfusion [6].
In contrast, we further showed that rats perfused with highly
purified active PR3 in concentrations up to 300 g did not develop
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Fig. 2. Renal localization of elastase and PR3 10 min after unilateral
perfusion of the left kidney as detected by indirect immunofluorescence.
Localization of elastase (A) and PR3 (B) in tubular epithelial cells. g,
Glomerulus. (Original mag.  400.)
proteinuria. The inability of PR3 to induce proteinuria might have
been due to perfusion of too low amounts of active enzyme in
comparison with elastase. As shown, in vitro activation of PMN
results in the release of  3 times more PR3 than elastase. In our
perfusion experiments, however, perfusion of 300 g PR3 (i.e. 20
times more than the lowest dose of elastase inducing proteinuria)
did not result in proteinuria. More importantly, the total proteolytic
activity of the perfused PR3 preparation was comparable to that of
elastase at the different dosages studied. So, it seems unlikely that
the absence of proteinuria was due to unsufficient amounts of
active PR3 in comparison with elastase. Recently, Johnson et al.
also mentioned in their review that infusion of 50 g active PR3
did not result in proteinuria [25]. However, in their hands an
additional rat perfused with 385 g PR3 developed severe protei-
nuria without any histological evidence of glomerular injury.
Besides their ability to degrade extracellular matrix proteins,
several studies have shown that neutral serine proteases can also
injure endothelial cells [26]. Recently, a difference was noted
between PR3 and elastase in their effect on cultured endothelial
cells, showing that both elastase and PR3 caused detachment of
endothelial cells, while PR3 also induced cytolysis [27]. Despite the
severe proteinuria induced after perfusion of active elastase, we
found no evidence for glomerular endothelial cell injury by light and
electron microscopy, which observation also corroborates the find-
ings of Johnson et al. [6].
The absence of cellular injury suggests that degradation of
glomerular basement components is involved in elastase-induced
proteinuria. As mentioned before, elastase is highly cationic at
neutral pH, and binding to the GBM probably occurs by charge
interaction with anionic sites present in the GBM. Heparan
sulphate, the anionic side chains of HSPG, is recognized as one
of the major determinants of this negative charge and is a main
determinant of the charge-dependent selectivity of the GBM. In
this study we showed that proteinuria occurring after renal perfu-
sion of 50 g elastase was associated with a strong decrease of HS
expression as estimated by IIF, while staining for HSPG core
protein was also decreased, but to a lesser extent. Infusion of lower
amounts of elastase also reduced staining for HS, while no
326 P. Heeringa et al.
# 1996 Blackwell Science Ltd, Clinical and Experimental Immunology, 105:321–329
Table 3. Urinary protein excretion 24 h and glomerular staining of heparan sulphate (HS) side chain and heparan sulphate core protein
after renal perfusion of elastase and PR3
Concentration Activity Proteinuria
Perfusate (g/0.5 ml) (mU) (mg/24 h) HS HSPG
Elastase 50 (6) 257 147.3m35.6*  
25 (3) 129 38.4m4.2*  
15 (3) 77 12.6m2.2*  
Elastase inactivated 50 (4) 0 1.5m0.5  
PR3 300 (4) 326 1.3m0.2  
100 (3) 109 1.8m0.3  
50 (3) 54 1.7m0.3  
PBS (4) 3.4m1.9  
Values represent meanms.e.m.
* P < 0.01 compared with PBS perfusion.
Rats were killed 24 h after perfusion. Intraglomerular expression of HS side chain and the core protein of HS proteoglycan (PG) was
estimated by indirect immunofluorescence using MoAb JM-403 (HS side chain) and a polyclonal goat antibody directed against the core
protein of HSPG. Labelling intensity was estimated on a semiquantitative scale (3): ÿ, absent; , weak; , mild; , intermediate;
, strong.
Fig. 3. Characterization of 24 h proteinuria by 12% SDS–PAGE after
perfusion of 50 g elastase (lanes 1 and 4), 50 g inactivated elastase (lane
2), 300 g PR3 (lane 3) and PBS (lane 5).
Fig. 4. Glomerular expression of heparan sulphate (HS) (A,C,E) and HS
proteoglycan (PG) core protein (B,D,F) by indirect immunofluorescence
double-staining 24 h after perfusion. Strong staining of the glomerular
basement membrane (GBM) is shown by both antibodies in kidney sections
of PBS- (A,B, PBS) and PR3- (C,D, proteinase 300 g) perfused rats. After
perfusion of 50 g active elastase staining for HS (E) was almost com-
pletely absent, while staining for HSPG core protein was somewhat reduced
(F). (Original mag.: A,B,  250; C–F,  400.)
# 1996 Blackwell Science Ltd, Clinical and Experimental Immunology, 105:321–329
apparent decrease in staining for HSPG core protein was seen at
those concentrations. One explanation might be that elastase
cleaves the HSPG molecule close to the NH2 terminus. Recently,
it has been shown that the HS side chains are attached to the core
protein very close to the NH2 terminus [28]. Therefore, enzymatic
removal of (a part of) the NH2 terminus leads to a complete loss of
HS side chains, whereas the major portion of the core protein
remains in the GBM. Moreover, Klebanoff et al. showed that
elastase-induced degradation of subendothelial cell matrix HSPG
in vitro generates several HSPG fragments of different size [14].
They further found that the smaller fragments are preferentially
released in the supernatant, while larger fragments remain bound to
the matrix. This might, additionally, explain why in our study
HSPG core protein still stained strongly positive after elastase
perfusion. Several other studies have indicated a prominent role for
neutrophil serine proteinases, especially elastase, in the degrada-
tion of HSPG [29–31]. In this respect, an interesting study was
done by Kowanko et al., who showed that neutrophil-mediated
degradation of cartilage proteoglycan was primarily induced by
elastase and cathepsin G, with only a minor role for PR3 [31].
The inability of PR3 to induce proteinuria was somewhat
surprising, since in vitro studies have shown that PR3 is similar
to the other PMN-derived neutral serine proteinases elastase and
cathepsin G in exhibiting a broad substrate specificity towards
GBM components [8,12]. Our in vitro data also show that PR3, like
elastase, is capable of digesting HSPG, although to a lesser extent.
The differences between elastase and PR3 in their ability to cleave
HSPG and inducing proteinuria in vivo may be explained by
differences in charge between these enzymes. Studies by Vogt
and colleagues have shown that glomerular binding of cationic
molecules is dependent on charge and size of the molecules [32]. In
their studies intravenously injected cationized ovalbumin, a small
molecule of 40 kD, only bound to the GBM when its isoelectric
point was > 10. PR3 and elastase are both small molecules, but
differ significantly in their isoelectric point (9.1 for PR3 versus
> 11 for elastase). Therefore, binding of elastase to negatively
charged molecules within the GBM will be much stronger than for
PR3. This was also shown by our in vitro studies comparing the
binding of elastase and PR3 with EHS–HSPG, although the
binding characteristics of the detecting antibodies may influence
the results to some extent. In vivo, the binding of PR3 to negatively
charged molecules is probably too weak to cause any damage.
Because of its low molecular weight, PR3 will then be rapidly
filtrated.
GBM components other than HSPG are also susceptible to
proteolytic attack by elastase in vitro [1]. We therefore wondered
whether the digestion of HSPG by elastase was selective for this
protein. Earlier studies have shown that the enzymatic removal of
HS from the GBM increases the permeability of the GBM for
positively charged, low molecular weight proteins like albumin
and native ferritin [33,34]. Furthermore, i.v. injection of the anti-
HS MoAb used in this study was shown to induce an acute
selective proteinuria [18]. Analysis of the elastase-induced protei-
nuria in this study by SDS–PAGE showed the predominance of
lower molecular weight proteins. In addition, by IIF we found no
decrease or alteration in expression of S-laminin, fibronectin or
collagen type IV compared with control perfused rats. These
observations may be explained by the preferential binding of
elastase to the negatively charged HSPG. Once bound, elastase
will cleave HSPG immediately, resulting in loss of the HS side
chains. Cleavage products of HSPG, but also elastase itself, will
then readily be filtrated without digesting other GBM components.
In addition, loss of negatively charged HSPG leads to proteinuria.
In conclusion, in vivo perfusion of g quantities of active
elastase induced a dose-dependent proteinuria, while infusion of
active PR3 did not. The elastase-induced proteinuria was asso-
ciated with a strong reduction of glomerular HS expression and, to
a lesser extent, of HSPG core protein. These studies indicate that
proteolytic cleavage of HSPG by elastase may be a contributing
factor to glomerular injury in PMN-dependent glomerulonephritis,
and suggest a minor role for PR3.
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